Park National Corp Johnson & Johnson Transaction History

Park National Corp

$2.82 Billion
Q3 2024

A detailed history of Park National Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Park National Corp holds 140,174 shares of JNJ stock, worth $21.8 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

140,174

Previous 179,485 21.9%

Holding current value

$21.8 Million

Previous $26.2 Million 13.41%

% of portfolio

0.8%

Previous 0.98%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 01, 2024	SELL	$145.48 - $167.38 $5.72 Million - $6.58 Million	-39,311 Reduced 21.9%	140,174 $22.7 Million
Q2 2024 Jul 15, 2024	SELL	$144.38 - $157.78 $9.39 Million - $10.3 Million	-65,003 Reduced 26.59%	179,485 $26.2 Million
Q1 2024 Apr 01, 2024	SELL	$155.22 - $162.74 $1.1 Million - $1.15 Million	-7,069 Reduced 2.81%	244,488 $38.7 Million
Q4 2023 Jan 02, 2024	SELL	$145.6 - $158.88 $601,036 - $655,856	-4,128 Reduced 1.61%	251,557 $39.4 Million
Q3 2023 Oct 02, 2023	SELL	$155.75 - $174.48 $774,077 - $867,165	-4,970 Reduced 1.91%	255,685 $39.8 Million
Q2 2023 Jul 03, 2023	SELL	$154.35 - $166.11 $1.5 Million - $1.61 Million	-9,688 Reduced 3.58%	260,655 $43.1 Million
Q1 2023 Apr 03, 2023	SELL	$151.05 - $180.26 $770,808 - $919,866	-5,103 Reduced 1.85%	270,343 $41.9 Million
Q4 2022 Feb 06, 2023	SELL	$160.2 - $179.79 $1.22 Million - $1.37 Million	-7,639 Reduced 2.7%	275,446 $48.7 Million
Q3 2022 Oct 03, 2022	BUY	$161.33 - $179.52 $391,870 - $436,054	2,429 Added 0.87%	283,085 $46.2 Million
Q2 2022 Jul 01, 2022	SELL	$168.19 - $186.01 $1.11 Million - $1.22 Million	-6,577 Reduced 2.29%	280,656 $49.8 Million
Q1 2022 Apr 01, 2022	SELL	$158.14 - $179.59 $781,844 - $887,892	-4,944 Reduced 1.69%	287,233 $50.9 Million
Q4 2021 Jan 04, 2022	SELL	$155.93 - $173.01 $377,662 - $419,030	-2,422 Reduced 0.82%	292,177 $50 Million
Q3 2021 Oct 01, 2021	SELL	$161.5 - $179.47 $1.24 Million - $1.38 Million	-7,690 Reduced 2.54%	294,599 $47.6 Million
Q2 2021 Jul 01, 2021	SELL	$159.48 - $171.07 $2.07 Million - $2.22 Million	-12,985 Reduced 4.12%	302,289 $49.8 Million
Q1 2021 Apr 01, 2021	SELL	$153.07 - $170.48 $1.53 Million - $1.71 Million	-10,014 Reduced 3.08%	315,274 $51.8 Million
Q4 2020 Jan 04, 2021	SELL	$137.11 - $157.38 $213,891 - $245,512	-1,560 Reduced 0.48%	325,288 $51.2 Million
Q3 2020 Oct 01, 2020	SELL	$140.38 - $153.83 $729,274 - $799,146	-5,195 Reduced 1.56%	326,848 $48.7 Million
Q2 2020 Jul 01, 2020	SELL	$128.81 - $155.51 $747,098 - $901,958	-5,800 Reduced 1.72%	332,043 $46.7 Million
Q1 2020 Apr 01, 2020	SELL	$111.14 - $153.99 $656,837 - $910,080	-5,910 Reduced 1.72%	337,843 $44.3 Million
Q4 2019 Jan 02, 2020	BUY	$127.5 - $146.44 $35,955 - $41,296	282 Added 0.08%	343,753 $50.1 Million
Q3 2019 Oct 01, 2019	BUY	$126.95 - $142.14 $565,054 - $632,665	4,451 Added 1.31%	343,471 $44.4 Million
Q2 2019 Jul 01, 2019	SELL	$131.15 - $144.24 $558,305 - $614,029	-4,257 Reduced 1.24%	339,020 $47.2 Million
Q1 2019 Apr 01, 2019	BUY	$125.72 - $139.79 $417,013 - $463,683	3,317 Added 0.98%	343,277 $48 Million
Q4 2018 Jan 02, 2019	SELL	$122.84 - $147.84 $13,635 - $16,410	-111 Reduced 0.03%	339,960 $43.9 Million
Q3 2018 Oct 02, 2018	BUY	$121.58 - $142.88 $139,573 - $164,026	1,148 Added 0.34%	340,071 $47 Million
Q2 2018 Jul 02, 2018	BUY	$119.4 - $131.76 $406,676 - $448,774	3,406 Added 1.02%	338,923 $41.1 Million
Q1 2018 Apr 02, 2018	SELL	$125.1 - $148.14 $923,738 - $1.09 Million	-7,384 Reduced 2.15%	335,517 $43 Million
Q4 2017 Jan 02, 2018	SELL	$131.22 - $143.62 $1.51 Million - $1.65 Million	-11,499 Reduced 3.24%	342,901 $47.9 Million
Q3 2017 Oct 02, 2017	BUY	$129.47 - $135.38 $45.9 Million - $48 Million	354,400	354,400 $46.1 Million

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park National Corp , based on Form 13F filings with the SEC.

News

Stay updated on Park National Corp with notifications on news.

Account

Park National Corp Johnson & Johnson Transaction History